“Novel In-Office Injectables for the Dermatology–Rheumatology Patient: Botulinum Toxin, Sodium Thiosulfate, and Hyaluronidase”. 2026. Canadian Dermatology Today 7 (3): 4-10. https://doi.org/10.58931/cdt.2026.73167.